This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Changzheng Hospital. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Yiyun Cheng: Innovator in Gene Therapy
Introduction
Yiyun Cheng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of gene therapy, particularly through his innovative patent that enhances transfection efficiency. His work is vital in the ongoing quest for effective treatments for gene-related diseases.
Latest Patents
Yiyun Cheng holds a patent for a "Composition for gene therapy or transfection, and preparation method and use thereof." This composition includes nucleic acid, natural polyphenol, and cationic molecules. The natural polyphenol contains several phenolic hydroxyl groups, which help eliminate free radicals, prevent cancer, fight inflammation, and provide antioxidant features. Compared to the delivery of cationic molecules alone, this composition significantly improves transfection efficiency by about 60-70%. It also reduces the effective transfection dose of cationic molecules by approximately 20 times, thereby minimizing toxicity and enhancing organism compatibility. Importantly, this composition does not introduce other chemical reagents, does not require synthesis, and boasts high biosafety. It can efficiently and safely deliver multiple nucleic acid molecules into cells, making it a promising candidate for treating gene-related diseases.
Career Highlights
Yiyun Cheng is affiliated with Shanghai Changzheng Hospital, where he continues to advance his research in gene therapy. His innovative approach and dedication to improving medical treatments have positioned him as a key figure in his field.
Collaborations
Yiyun Cheng has collaborated with notable colleagues, including Jianru Xiao and Wanwan Shen. Their combined expertise contributes to the advancement of research in gene therapy and related fields.
Conclusion
Yiyun Cheng's contributions to gene therapy through his innovative patent demonstrate his commitment to improving healthcare solutions. His work not only enhances transfection efficiency but also offers a safer and more effective approach to treating gene-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile